Case studies outlining use of nebulized morphine for patients with end-stage chronic lung and cardiac disease
- 31 May 1993
- journal article
- case report
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 8 (4) , 221-225
- https://doi.org/10.1016/0885-3924(93)90131-e
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Does pharmacological treatment affect the sensation of breathlessness in terminal cancer patients?Palliative Medicine, 1991
- Long-term management of respiratory symptoms in advanced cancerJournal of Pain and Symptom Management, 1990
- Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease.Thorax, 1989
- OPIOID INHIBITION OF NEURALLY MEDIATED MUCUS SECRETION IN HUMAN BRONCHIThe Lancet, 1989
- Effects of Oral Morphine on Breathlessness and Exercise Tolerance in Patients with Chronic Obstructive Pulmonary DiseaseAmerican Review of Respiratory Disease, 1988
- Heroin inhalation and asthma.BMJ, 1988
- Opioid modulation of non‐cholinergic neural bronchoconstriction in guinea‐pig in vivoBritish Journal of Pharmacology, 1988
- Effects of Dihydrocodeine, Alcohol, and Caffeine on Breathlessness and Exercise Tolerance in Patients with Chronic Obstructive Lung Disease and Normal Blood GasesNew England Journal of Medicine, 1981
- Diminished Ventilatory Response to Hypoxia and Hypercapnia after Morphine in Normal ManNew England Journal of Medicine, 1975